Clinical Trials · NCT03648554
Researching an Effect of GLP-1 Agonist on Liver STeatosis (REALIST)
- Phase
- Phase 4
- Recruitment status
- Unknown
- Sponsor
- Central Hospital, Nancy, France
- Enrollment
- 93
- Start date
- Sep 2019
- Locations
- 9 sites, France
- Primary endpoint
- Responder's proportion difference between the two groups (dulaglutide (TRULICITY®) on top of dietary reinforcement vs. dietary reinforcement alone)